These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties. Johnsamuel J; Lakhi N; Al-Madhoun AS; Byun Y; Yan J; Eriksson S; Tjarks W Bioorg Med Chem; 2004 Sep; 12(18):4769-81. PubMed ID: 15336255 [TBL] [Abstract][Full Text] [Related]
6. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position. Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W Appl Radiat Isot; 2004 Nov; 61(5):1125-30. PubMed ID: 15308203 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3'-carboranyl thymidine analogues. Yan J; Naeslund C; Al-Madhoun AS; Wang J; Ji W; Cosquer GY; Johnsamuel J; Sjöberg S; Eriksson S; Tjarks W Bioorg Med Chem Lett; 2002 Aug; 12(16):2209-12. PubMed ID: 12127539 [TBL] [Abstract][Full Text] [Related]
8. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Barth RF; Yang W; Wu G; Swindall M; Byun Y; Narayanasamy S; Tjarks W; Tordoff K; Moeschberger ML; Eriksson S; Binns PJ; Riley KJ Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17493-7. PubMed ID: 18981415 [TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors. Byun Y; Thirumamagal BT; Yang W; Eriksson S; Barth RF; Tjarks W J Med Chem; 2006 Sep; 49(18):5513-23. PubMed ID: 16942024 [TBL] [Abstract][Full Text] [Related]
10. N3-substituted thymidine bioconjugates for cancer therapy and imaging. Khalil A; Ishita K; Ali T; Tjarks W Future Med Chem; 2013 Apr; 5(6):677-92. PubMed ID: 23617430 [TBL] [Abstract][Full Text] [Related]